Duration of Type 2 Herpes Activity in the Body
Type 2 herpes (HSV-2) is a life-long infection that remains active in the body indefinitely, with periods of latency interrupted by recurrent symptomatic or asymptomatic viral shedding. 1
Infection Phases and Viral Activity
- After initial infection, HSV-2 establishes latency in the sacral ganglia, where it remains dormant between recurrences 1
- The virus alternates between periods of latency and reactivation throughout the infected person's lifetime 1
- During latency, the virus remains in a non-multiplying episomal form in the nuclei of neurons in the ganglia 1
Recurrence Patterns
- Nearly 89% of patients with HSV-2 will experience at least one symptomatic recurrence after the initial infection 2
- Recurrence frequency varies significantly between individuals:
- Men tend to have approximately 20% more recurrences than women (median monthly recurrence rate of 0.43 for men vs. 0.33 for women) 2
Changes in Recurrence Rates Over Time
- Clinical reactivation of HSV-2 tends to decrease in frequency over time 3
- Significant decreases in recurrence rates are typically observed between the first and second years of infection 3
- Patients followed for more than 4 years showed a median decrease of two recurrences between years 1 and 5 3
- However, about 25% of patients may experience an increase of at least one recurrence in year 5, highlighting the variability among infected individuals 3
Asymptomatic Viral Shedding
- Even when no symptoms are present, HSV-2 can be actively shedding (reactivating):
- Asymptomatic cervical shedding is three times more frequent during the first three months after resolution of primary HSV-2 infection compared to later periods 5
Clinical Manifestations During Active Periods
- Each episode or recurrence typically lasts less than 10 days but may be prolonged due to secondary bacterial infection or immunosuppression 1
- Recurrences are characterized by:
- Initial redness at the site
- Development of papules and vesicles
- Formation of shallow ulcers or erosions that eventually crust and heal without scarring 1
Management Implications
- Since HSV-2 is a life-long infection with ongoing potential for viral shedding, long-term management strategies may be necessary 1, 6
- Suppressive antiviral therapy can reduce recurrence frequency by ≥75% in patients with frequent outbreaks 1
- After one year of continuous suppressive therapy, reassessment is recommended as recurrence patterns may change over time 1
Important Caveats
- Most cases of genital herpes (80-90%) progress subclinically but may become symptomatic at any time 1
- Even during asymptomatic periods, sexual transmission of HSV can occur due to viral shedding 1
- The risk of transmission to sexual partners remains throughout the infected person's lifetime, though it may decrease over time as viral shedding patterns change 1, 3